Manufacturing Logistics Webinars

  1. How End Users Can Drive Single-Use Harmonization 9/12/2025

    Though progress has been made in supplier-created standards, broader harmonization is difficult to balance in a competitive supplier market. In this segment from the Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up,” the panelists encourage self-regulation for the industry. This bottom-up approach, where standardization begins with end users, will ultimately put competitive pressure on suppliers.

  2. Addressing Mismatched Connectors And Overcoming Validation Hurdles 9/12/2025

    During the Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up,” audience members indicated mismatched connectors and validation challenges as their biggest pain points. In this segment, our panelists respond to the audience and weigh in on how to mitigate these difficulties.

  3. Taking A Risk-Based Approach To Harmonization 9/12/2025

    In this segment from the Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up,” our panelists a risk-based approach to standardizing SUS. They agree that a flexible strategy requires up-front pre-validation and pre-qualification, but it’s worth the initial investment.

  4. Planning For Flexibility And Supply Chain Resilience 9/12/2025

    In this segment from the Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up,” our panelists discuss the importance of working with your quality team to plan for flexibility, a lesson the industry learned the hard way during the COVID-19 supply chain disruptions.

  5. Single-Use Standardization Starts Internally 9/12/2025

    We've all heard the expression: If you want to change the world, start at home. Single-use standardization is no different. In this segment from the Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up,” our panelists Mark Petrich, Ph.D., and Frank Gillam, Ph.D., reflect on their success and struggles standardizing single-use systems within their respective organizations.

  6. Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D. 8/12/2025

    On this episode of Better Biopharma, Interius BioTherapeutics’ Sianny Christanti and Babu Medi, Ph.D., explain how the company is re-engineering a lentiviral vector to enable INT2104, its off-the-shelf, in vivo CAR T-cell therapy. They discuss the vector's design and its manufacturability, as well as the analytical and regulatory challenges of bringing this first-in-human therapy to the clinic.

  7. Secure Your Sensitive Drug Substances 8/7/2025

    Explore the risks of freeze and thaw cycles on biological products and how an advanced plate freezing platform protects sensitive molecules with precision and ease.

  8. Unlocking The Cold Chain Of Proteins 7/3/2025

    Discover how controlled freezing minimizes cryoconcentration and protein denaturation in bulk drug substances. Learn about efficient, scalable freezing solutions for enhanced product stability.

  9. Navigating The New USP Chapter <382> For Elastomeric Closures 6/24/2025

    Dive into the scope of <382> for pharmaceutical closures and the regulatory landscape, which includes new required tests, instrumentation for compliance, and recommendations on implementation.

  10. Manufacturing Considerations For Viral & Non-Viral Platform Selection 6/24/2025

    In this webinar, a panel of experts spanning the lentiviral vector, exosome and oncolytic virus fields will discuss the impact of manufacturing considerations on their respective platform selection and ongoing product/process development strategies.